EU body recommends use of remdesivir to treat virus
The Hague: The European Medicines Agency said Thursday it has recommended authorising the use of the anti-viral drug remdesivir to treat the new coronavirus.
"Remdesivir is the first medicine against COVID-19 to be recommended for authorisation in the EU," the agency said.
It said the recommendation still needs approval from the European Commission, which is due to make a decision in the coming week.
At least two major US studies have shown that remdesivir can reduce the duration of hospital stays for COVID-19 patients.
Washington authorised the emergency use of the medicine -- which was originally intended as a treatment for Ebola -- on May 1, followed by several Asian nations including Japan and South Korea.
EMA's human medicines committee said it has recommended granting a conditional marketing authorisation to remdesivir for the treatment of COVID-19 in adults and adolescents from 12 years of age who are suffering pneumonia and require extra oxygen. - AFP